Colin Reisner

Colin Reisner

Chief Executive Officer at
Pearl Therapeutics, Inc.
Health Technology
Consumer Services
Commercial Services

Profile

Colin Reisner is currently Chief Executive Officer at Pearl Therapeutics, Inc. since 2007 and a Member of the American Thoracic Society, Inc. Former positions include Executive Director-Global Respiratory Development at Novartis Corp., Senior Director-Respiratory Division at GlaxoSmithKline, Inc., Head-Clinical Respiratory at AstraZeneca PLC, Assistant Consulting Professor at Duke University, Assistant Consulting Professor at Yale University, and Principal at Boehringer Ingelheim Corp.
Education includes undergraduate studies at the University of the Witwatersrand.

Colin Reisner active positions

CompaniesPositionStart
Chief Executive Officer 2007-09-30
Corporate Officer/Principal -

Former positions of Colin Reisner

CompaniesPositionEnd
ASTRAZENECA PLC Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Colin Reisner's experience

Training of Colin Reisner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

30

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services